MAJI — Nextel Medical Corp.
—
OTC ·
Communication Services ·
Wireless Telecommunication Services ·
CIK 1492448 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Yahoo Snapshot (yfinance, live)
Total Revenue
$-12,830
EBITDA
—
Free Cash Flow
—
Enterprise Value
$1,148,469
Total Cash
$9,010
Total Debt
$714,229
Shares Out
56,048,470
Trailing EPS
$-0.03
Book Value
$-0.02
ROE
—
ROA
—
Div Yield
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ASTS | AST SpaceMobile, Inc. | $35.76B | $119.70 | — |
| SATS | EchoStar CORP | $19.51B | $123.12 | — |
| VSAT | VIASAT INC | $11.06B | $81.40 | — |
| GSAT | Globalstar, Inc. | $10.77B | $83.59 | — |
| IRDM | Iridium Communications Inc. | $5.30B | $50.16 | — |
News headlines (Yahoo Finance, 1h cache)
NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
2026-05-11 15:53 · Yahoo
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test
2026-04-07 14:30 · Yahoo
Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value
2026-03-16 14:15 · Yahoo
Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions
2026-03-05 18:00 · Yahoo
Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition
2026-02-10 15:30 · Yahoo
Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization
2025-12-11 17:15 · Yahoo
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
2025-12-05 16:00 · Yahoo
Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
2025-12-02 18:45 · Yahoo
Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value
2025-11-17 20:40 · Yahoo
Exousia Pro Announces Breakthrough In Exosome-Based Delivery
2025-11-04 15:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.